Condition
Omega-3 Polyunsaturated Fatty Acids
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 1 (1)
Trial Status
Completed2
Not Yet Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07304921Phase 1Completed
Novel Approach to Increase EPA and DHA Levels
NCT06995586Not ApplicableNot Yet Recruiting
Dietary Supplements in Patients With Coronary Artery Bypass Grafting for Improving the Quality of Healthcare Delivery.
NCT04572789Not ApplicableCompleted
Omega-3 Fatty Acid in the Prevention of Migraine
NCT02720250Not ApplicableUnknownPrimary
Omega-3 Fatty Acids Enriched Food and Microvascular Reactivity
Showing all 4 trials